Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Impact of COX2 Inhibitor for Regulation of PD-L1 Expression in Non-small Cell Lung Cancer

KATSUHIKO SHIMIZU, RIKI OKITA, SHINSUKE SAISHO, AI MAEDA, YUJI NOJIMA and MASAO NAKATA
Anticancer Research August 2018, 38 (8) 4637-4644; DOI: https://doi.org/10.21873/anticanres.12768
KATSUHIKO SHIMIZU
Department of General Thoracic Surgery, Kawasaki Medical School, Kurashiki, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kshimizu{at}med.kawasaki-m.ac.jp
RIKI OKITA
Department of General Thoracic Surgery, Kawasaki Medical School, Kurashiki, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHINSUKE SAISHO
Department of General Thoracic Surgery, Kawasaki Medical School, Kurashiki, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AI MAEDA
Department of General Thoracic Surgery, Kawasaki Medical School, Kurashiki, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUJI NOJIMA
Department of General Thoracic Surgery, Kawasaki Medical School, Kurashiki, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAO NAKATA
Department of General Thoracic Surgery, Kawasaki Medical School, Kurashiki, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 38 no. 8 4637-4644
DOI 
https://doi.org/10.21873/anticanres.12768
PMID 
30061230

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received June 7, 2018
  • Revision received June 21, 2018
  • Accepted June 27, 2018
  • Published online July 30, 2018.

Copyright & Usage 
Copyright© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. KATSUHIKO SHIMIZU⇑,
  2. RIKI OKITA,
  3. SHINSUKE SAISHO,
  4. AI MAEDA,
  5. YUJI NOJIMA and
  6. MASAO NAKATA
  1. Department of General Thoracic Surgery, Kawasaki Medical School, Kurashiki, Japan
  1. Correspondence to: Katsuhiko Shimizu, Department of General Thoracic Surgery, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama 701-0192, Japan. Tel: +81 864641124, Fax: +81 864641124, e-mail: kshimizu{at}med.kawasaki-m.ac.jp
View Full Text

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 38, Issue 8
August 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Impact of COX2 Inhibitor for Regulation of PD-L1 Expression in Non-small Cell Lung Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 14 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Impact of COX2 Inhibitor for Regulation of PD-L1 Expression in Non-small Cell Lung Cancer
KATSUHIKO SHIMIZU, RIKI OKITA, SHINSUKE SAISHO, AI MAEDA, YUJI NOJIMA, MASAO NAKATA
Anticancer Research Aug 2018, 38 (8) 4637-4644; DOI: 10.21873/anticanres.12768

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Impact of COX2 Inhibitor for Regulation of PD-L1 Expression in Non-small Cell Lung Cancer
KATSUHIKO SHIMIZU, RIKI OKITA, SHINSUKE SAISHO, AI MAEDA, YUJI NOJIMA, MASAO NAKATA
Anticancer Research Aug 2018, 38 (8) 4637-4644; DOI: 10.21873/anticanres.12768
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Detection of COX-2 in liquid biopsy of patients with prostate cancer
  • Recovery of the Sensitivity to Anti-PD-1 Antibody by Celecoxib in Lung Cancer
  • Impact of Concomitant Medication Administered at the Time of Initiation of Nivolumab Therapy on Outcome in Non-small Cell Lung Cancer
  • Inhibition of COX-2 and EGFR by Melafolone Improves Anti-PD-1 Therapy through Vascular Normalization and PD-L1 Downregulation in Lung Cancer
  • Google Scholar

More in this TOC Section

  • NK92-exo Induces Ferroptosis in A549 Cells by Targeting a miR-663a-SLC11A2 Axis
  • PD-1+Tim-3+CD103+ CD8+ Tumor-infiltrating Lymphocytes Are Associated With Favorable Outcomes in Colorectal Cancer
  • Sulfasalazine an Inhibitor of System xC− (Cystine/glutamate Antiporter), Combined With Recombinant Methioninase, Inhibits Both Cancer and Normal Cells, Suggesting Lack of Cancer Selectivity of Cysteine Restriction
Show more Experimental Studies

Keywords

  • Non-small cell lung cancer (NSCLC)
  • PD-L1
  • COX2
  • COX2 inhibitor
  • co-localization
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire